REQUEST A DEMO
Total
USD $0.00
Search more companies

Middle East Pharmaceutical Industries Company (Saudi Arabia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Middle East Pharmaceutical Industries Company Profile Updated: January 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Middle East Pharmaceutical Industries Company is an enterprise located in Saudi Arabia, with the main office in Riyadh. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on September 13, 1998. There was a net sales revenue increase of 24% reported in Middle East Pharmaceutical Industries Company’s latest financial highlights for Q2C2026. A growth of 22.87% was recorded in its total assets. The enterprise’s net profit margin increased by 0.33% in 2026.

Headquarters
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180
Riyadh; Al-Riyadh; Postal Code: 11491

Contact Details: Purchase the Middle East Pharmaceutical Industries Company report to view the information.

Website: http://www.avalonpharmaceutical.com

Basic Information
Outstanding Shares:
Purchase the Middle East Pharmaceutical Industries Company report to view the information.
Financial Auditors:
Purchase the Middle East Pharmaceutical Industries Company report to view the information.
Incorporation Date:
September 13, 1998
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
42.175%
Purchase this report to view the information.
14.7%
Subsidiaries
Avalon Pharma Uk Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Middle East Pharmaceutical Industries Company report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SAR. Absolute financial data is included in the purchased report.
Net sales revenue
24%
Total Operating Revenue
24.15%
Operating Profit
33.37%
EBITDA
29.83%
Net Profit/Loss for the Period
25.99%
Total Assets
22.87%
Total Equity
15.68%
Operating Profit Margin
1.78%
Net Profit Margin
0.33%
Return on Equity (ROE)
1.02%
Debt / Equity
9.14%
Quick Ratio
-0.05%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?